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Abstract: Hypertension is one of the most prevalent diseases and is often called the “silent killer” 
because there are usually no early symptoms. Hypertension is also associated with multiple 
morbidities, including chronic kidney disease and cardiovascular disease. Early detection and 
intervention are therefore important. The current routine method for diagnosing hypertension is 
done using a sphygmomanometer, which can only provide intermittent blood pressure readings 
and can be confounded by various factors, such as white coat hypertension, time of day, exercise, 
or stress. Consequently, there is an increasing need for a non-invasive, cuff-less, and continuous 
blood pressure monitoring device. Multi-site photoplethysmography (PPG) is a promising new 
technology that can measure a range of features of the pulse, including the pulse transit time of the 
arterial pulse wave, which can be used to continuously estimate arterial blood pressure. This is 
achieved by detecting the pulse wave at one body site location and measuring the time it takes for it 
to reach a second, distal location. The purpose of this review is to analyze the current research in 
multi-site PPG for blood pressure assessment and provide recommendations to guide future 
research. In a systematic search of the literature from January 2010 to January 2019, we found 13 
papers that proposed novel methods using various two-channel PPG systems and signal 
processing techniques to acquire blood pressure using multi-site PPG that offered promising 
results. However, we also found a general lack of validation in terms of sample size and diversity 
of populations. 
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1. Introduction 
Hypertension (HTN), defined as a blood pressure (BP) above 140/90 mmHg on two or more 
occasions, is one of the most prevalent diseases, affecting over 1 billion people world-wide [1]. The 
European Society of Cardiology and the European Society of Hypertension estimates that by 2025, 
the number of affected people will be 1.5 billion [1]. HTN is often called the “silent killer” because 
there are usually no symptoms, but it is associated with chronic kidney disease, cardiovascular 
disease, and death [2]. In addition, hypertension in pregnancy is associated with preterm birth, still 
birth, intrauterine growth restrictions, neonatal thrombocytopenia, and bronchopulmonary 
dysplasia [3]. Therefore, early detection and intervention are critical. 
1.1. The Need for a Non-Invasive Continuous Blood Pressure Monitor 
The current industry gold standards of blood pressure assessment are the manual 
sphygmomanometer (BP cuff) and invasive blood pressure (IBP) measurements [4]. The invasive 
arterial line is currently only used in high-risk surgical patients or critically ill patients who require 
instantaneous BP measurements [5]. As expected, it is not used outside of the inpatient setting 
because of the risks associated with arterial cannulation, such as temporary occlusion, infection, or 
vascular damage [5]. The cuff-based sphygmomanometer is the most frequently used method of BP 
measurement in hospitals, in family practice offices, and at home. While the manual auscultatory 
method is the gold standard, the automatic BP cuff is also often used because of its convenience. The 
automatic BP cuff depends on the measurement of oscillometric changes in pressure during cuff 
deflation [6]. However, in both BP cuff methods, BP can only be measured intermittently and can be 
affected by factors such as white coat HTN, masked HTN, caffeine, exercise, or stress [7]. These 
measurements also provide no additional information on the cardiovascular status of the patient. 
Intermittent measurements using a sphygmomanometer are therefore not an ideal method for 
monitoring the long-term management of HTN [8]. Additionally, ambulatory home BP 
self-monitoring has been shown to be able to detect HTN disorders earlier than office measurements 
[9]. There are currently 24-h ambulatory BP monitoring (24hABPM) devices that can measure BP 
intermittently over the span of a day that have been shown to improve accuracy and predict 
cardiovascular risk. While the 24hABPM is superior to the BP cuff methods in that it can track BP 
trends throughout the day, it is not entirely non-invasive. The patient has to carry the device with an 
attached cuff that is set to inflate once every 15–20 min [10], which can be distracting and 
uncomfortable at the least, and could even cause microvascular damage (bruising) and pain in some 
patients [11]. In addition, the use of this device is costly [10]. As the prevalence of HTN increases, 
there is a growing need for a wearable, cuff-less, and non-invasive BP monitor that is cost-effective 
and can continuously monitor a patient’s blood pressure throughout day-to-day activities. 
1.2. Photoplethysmography to Estimate BP 
Photoplethysmography (PPG) is a technology that illuminates perfused tissue and then 
measures light that is either reflected or transmitted back to a photosensor, giving a measurement of 
blood volume [12]. Traditionally, PPG has been used to measure oxygen saturation in the finger, 
widely known as the pulse oximetry technique; however, PPG has also been shown to be able to 
detect changes in blood volume and the pulse wave of blood flow during systole [12]. The ability of 
PPG to detect the arterial pulse wave is a promising method for obtaining continuous BP 
measurements in a small and convenient wearable device. There have been increasing numbers of 
studies exploring this potential over the past decade, investigating using PPG in combination with 
electrocardiography (ECG), ballistocardiography (BCG), phonocardiography (PCG), impedance 
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plethysmography (IPG), and tonometry [13]. Notably, many papers use a combination of ECG and 
PPG to estimate BP, with ECG used to determine the start of systole and PPG used in the periphery 
to determine the time taken for the pulse wave to reach a certain distance. This measured time is 
known as the pulse arrival time (PAT), which is defined as the time it takes the pulse wave to travel 
from the heart to the periphery and is proportional to BP [14]. 
1.3. Vagueness of Terminology 
One of the difficulties of understanding research in PPG is the interchangeability of several key 
terms. This inconsistency in terminology can create confusion between research questions, protocol 
development, and findings, so we wanted to address it early in the review. In many publications, 
PAT is used interchangeably with pulse transit time (PTT). These two are not the same; the key 
difference is when this time interval starts. The beginning of the PAT is measured from the R wave 
of the ECG; therefore, it includes the pre-ejection period (PEP), which is the time it takes for blood to 
leave the heart after the heart’s electrical impulse [15]. PTT on the other hand is defined as the time it 
takes for a pulse wave to travel a known distance and does not include the PEP. It is inversely 
proportional to pulse wave velocity (PWV), which is the speed of the pulse wave along the arterial 
vessel [16]. Another point of confusion is that multi-site PPG is often used to describe a system that 
uses two PPG probes, but it can extend up to multiple channels [17]. In this review, we will consider 
dual PPG (two probes) as the key type of multi-site PPG in blood pressure assessment. 
1.4. Multi-Site PPG 
One of the limitations of the ECG–PPG method is that the PAT includes the PEP. This artifact 
reduces the accuracy of the BP estimation [15]. One of the ways to account for this is to measure the 
pulse wave at a proximal location rather than to measure the electrical impulse of the heart. Several 
studies have examined multi-site dual PPG based on just two PPG sensors, in which the ECG is 
replaced by a second PPG, thereby removing the confounding PEP component [16]. The resulting 
time interval from when the pulse wave is detected by the first PPG to when it is detected by the 
distal PPG is known as the pulse transit time (PTT), which is more accurately correlated to BP than 
the PAT [15]. The two PPG probes can be relatively proximal–distal, that is, not directly connected in 
the vascular tree (e.g., forehead to toe) [18], or they can be proximal–distal along the same artery 
(e.g., proximal brachial to distal brachial artery), as shown in Figure 1 [16]. Figure 2 shows an 
example of multi-site PPG being used to calculate PTT such that it is significantly correlated (p < 
0.001) with systolic BP (SBP). Note that each data point in Figure 2 represents a subject for either PTT 
(ear to toe) or (finger to toe), where a total of 116 subjects were used in the analysis. 
 
Figure 1. A visualization of the methods multi-site photoplethysmography (PPG) to measure the 
pulse transit time (PTT). Multisite PPG can make use of twos PPG probes, one proximal and one 
distal, to measure the time it takes for the pulse wave to travel a distance. (A,B) Two-location dual 
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PPG/iPPG systems. (C) iPPG system. (D) Single artery dual PPG system. (E) Multiple wavelengths 
system. ECG—electrocardiography, IPG—impedance plethysmography, 
BCG—ballistocardiography, PCG—phonocardiography, PPG—photoplethysmography, 
iPPG—image-based PPG, and MWPPG—multi-wavelength PPG. 
 
Figure 2. Dual probe multi-site PPG-derived pulse transit time (PTT) correlation with systolic blood 
pressure (SBP). The data used in this figure were adapted from Allen and Murray [19]. 
We performed a literature search for all research from January 2010 to January 2019 regarding 
multi-site PPG as a method for BP measurement. The purpose of this review is to gain an 
understanding of multi-site PPG as one of the potential technologies amongst several (Figure 1) to 
assess the current trends in the literature and to guide future research. We found that the amount of 
research in this field is limited. The majority of the studies on multi-site PPG had small sample sizes 
(e.g., typically 5–20 healthy subjects), with no hypertensive subjects or subjects with co-morbidities. 
Therefore, it appears that there is a lack of validation for this technology in clinical groups. 
2. Methods 
We conducted a thorough literature search using PubMed for articles exploring the use of 
multi-site PPG for BP measurement from 1/1/2010 to 1/1/2019. PubMed was used because it gave 
access to journal articles as well as conference proceedings. We decided to limit our search to the 
most recent decade, i.e., January 2010 to January 2019, because we were interested in the trend of the 
development of this technology in the recent decadal time frame. Note that the typical time frame is 
the most recent decade [20–22]. We used the following search terms, combined with “OR”, using 
PubMed’s advanced search feature: ppg blood pressure determination, ppg blood pressure 
estimation, ppg hypertension estimation, ppg non-invasive blood pressure, ppg cuffless blood 
pressure, ppg cuff-less blood pressure, photoplethysmographic blood pressure determination, 
photoplethysmographic blood pressure estimation, photoplethysmographic hypertension 
determination, photoplethysmographic hypertension estimation, non-invasive hypertension 
classification, non invasive blood pressure monitoring, pulse transit time blood pressure estimation, 
multi-ppg blood pressure, multi-site ppg blood pressure, and multi-photoplethysmographic blood 
pressure. Our initial searches returned a significant number of studies regarding arterial stiffness 
and vascular disease; we therefore added the search term “NOT arterial stiffness.” We are aware of 
the relatedness of vascular disease with hypertension [23]; however, including analysis of vascular 
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disease via PPG would mean including many studies unrelated to BP. Therefore, we decided to limit 
the scope of our study to multi-site PPG for the analysis of BP in the hope that we could make more 
meaningful and BP focused recommendations.  
We included any publication that examined multi-site PPG as a method for BP measurement. 
Our exclusion criteria included animal studies, review articles, articles that are not accessible in the 
English language (see the Appendix), articles in which PPG was not used to estimate blood pressure, 
and articles that validated a trademarked PPG device with no discussion of the PPG technology or 
waveform itself. From January 2010 to January 2019, our search found 13 papers that fit the inclusion 
criteria (Figure 3).  
 
Figure 3. Flow chart of included studies. Thirteen studies could be included out of 1098 articles 
published between January 2010 and January 2019. 
3. Results 
Our PubMed search found 13 publications that studied multi-site PPG technology; all but one 
paper looked at using two measurement sites with a two-probe system [24]. The two probes are used 
to measure PTT (or its inverse PWV), which is correlated with BP. From January 2010 to January 
2019, multi-site PPG publications followed a growing trend (Figure 4). In our analysis, we 
determined the sample sizes of each paper, the inclusion of any subjects with HTN or co-morbidities, 
and the method used as the gold standard to collect the reference BP measurements for comparison. 
Of these papers, only three had a sample size of more than 30 subjects: one each in 2011 [18], 2017 
[16], and 2018 [25]. In addition, most of the papers either used healthy subjects with no HTN, 
co-morbidities, or pregnant women, or used health statuses that were undisclosed. One paper [26] 
compared hypertensive (N = 10) and normotensive (N = 10) subjects, as well as patients undergoing 
coronary angiography (N = 4). Another publication collected data from patients undergoing general 
anesthesia (N = 35) [18]. 
 
Figure 4. Cumulative count of multi-site PPG BP related studies from January 2010 to January 2019 
showing an increase in the number of studies. 
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3.1. Gold Standards 
Several of the papers did not use the gold standard BP measurement methods (inter-arterial line 
or sphygmomanometer) for their comparisons. Instead, they used less validated methods for 
obtaining the reference BP, such as devices that employ the volume-clamp method, other PPG 
methods, applanation tonometry, or no reported reference at all. The volume-clamp method, also 
known as finger arterial non-invasive BP, uses a PPG probe to measure the volume of blood in the 
fingertip and a beat-to-beat adjusting cuff that exerts pressure to maintain the volume detected by 
the PPG. In theory, this cuff pressure is equal to the systolic BP. Some publications have verified its 
validity in different applications [27], but others have shown its measurements to be different from 
invasive BP measurements [28]. Since the automatic sphygmomanometer is widely used in the 
clinical setting, for our study, we considered an automatic BP cuff as an appropriate gold standard 
[6]. Only eight publications used an appropriate gold standard for assessing the reference BP, where 
two used invasive arterial blood pressure and six used a sphygmomanometer (manual or automatic) 
(Figure 5) 
 
Figure 5. A representation of the gold standards used by each study to obtain the reference blood 
pressure. BP cuff—sphygmomanometer, either manual or automatic; not validated—Volume-clamp 
method, applanation tonometry (use of pressure sensors on the artery to detect systolic BP), or 
another PPG technology that has not been fully validated as the gold standard for BP measurement; 
invasive IBP—invasive arterial blood pressure. 
3.2. Induced Changes in BP 
Many studies included a protocol that induced changes in BP during measurement, as shown in 
Figure 6. In addition to physical exercise, other experimental tasks were used to drive changes in the 
autonomic nervous system and thus alter BP as a response through the baroreceptors and 
vasoconstriction. Such techniques included anesthesia, the Valsalva maneuver, a tilt table, and 
cold-pressor test. In other techniques, a brachial cuff was used to occlude the brachial artery, which 
causes a rise in blood pressure in the carotid artery where the measurements take place [29]. Using 
these techniques to induce changes in the blood pressure allowed the studies to show that the 
technology is sensitive and accurate over some range of BPs. However, the range of induced BP 
values is generally limited.  
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Figure 6. A representation of the methods used in the studies to provoke changes in blood pressure 
during validation of the multi-site PPG technique. Exercise = stationary calf raises, hand grip 
exercise, or physical activity immediately before measurement; anesthesia = general anesthesia; 
cuff-induced hypertension = BP cuff used to occlude the brachial artery to artificially raise the BP in 
the carotid; Valsalva maneuver = exhaling against a closed glottis; N/R = not reported. 
3.3. Accuracy of BP Estimation 
The accuracy of BP estimations of each analyzed publication is summarized in Table 1. There 
were two methods used to determine the accuracy in comparison with the reference BP: mean 
absolute difference and Pearson’s correlation coefficient (r). Three publications did not analyze their 
method in comparison to a reference BP. One publication expressed reliability in their 
measurements by showing that beat-to-beat variations of the measured PWV was less than 15% [29]. 
Another analyzed the correlation of PTT measurements from the wrist to different fingers (index, 
middle, ring, little) and found an absolute correlation value of 0.95 [30]. The third publication 
compared the PTT using their proposed method with PTT using the ECG–PPG method giving  r 
value of 0.86 ± 0.06 [31]. Only one study found that PTT was poorly correlated with BP [32]. 
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Table 1. Summary of findings of all papers included in this review.  
Year Authors # Subjects  Age Range of 
Subjects (Years) 
Gold Standard Parameters Measured Mean BP Absolute 
Difference 
Absolute of value of 
correlation coefficient between 
estimated BP (or  PTT feature) 
and referenced BP 
2018 Liu et al. [26] 
N1 = 10 
N2 = 10 
N/R Finometer PTT (ECG, ICG, FingerPPG) 
PTT (MW FingerPPG) 
1.86 mmHg MAP N/R 
N3 = 4  N/R IBP 2.72 mmHg MAP N/R 
2018 Wang et al. [25] N1 = 30 20–27 BP Cuff PTT (WristPPG to ArmPPG with MA) N/R 
r = 0.75 SBP 
r = 0.78 DBP 
2018 Viejo et al. [24] N1 = 15 20–38 BP Cuff PTT (2 cheeksPPG, foreheadPPG) N/R r = 0.85 BP 
2017 Nabeel et al. [16] N1 = 35 23–32 BP Cuff 
PTT (CarotidPPG to CarotidPPG) 
PTT (CarotidPPG to FingerPPG) 
PTT (ECG to CarotidPPG) 
N/R 
r = 0.74 SBP 
r = 0.77 DBP 
r = 0.78 MAP 
2017 Nabeel et al. [29] N1 = 5 24–30 Tonometry PTT (CarotidPPG to CarotidPPG) N/R N/R 
2017 Beckmann et al. [30] N1 = 5 25–36 N/R 
PTT (WristPPG to Index FingerPPG) 
PTT (WristPPG to Middle FingerPPG) 
PTT (WristPPG to Ring FingerPPG) 
PTT (WristPPG to Little FingerPPG) 
N/R N/R 
2017 Zhang et al. [33] N1 = 29 20–30 BP Cuff 
PTT (FacePPG to FingerPPG) 
PTT (TemplePPG to WristPPG) 
N/R r > 0.6 SBP in 75.9% subjects 
2016 Nabeel et al. [34]  N1 = 17 21–34 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R 
r = 0.68 SBP 
r = 0.71 DBP 
r = 0.72 MAP 
2016 Liu et al. [35] N1 = 10 22–26 Finometer PTT (ECG to FingerPPG) 
PTT (MW FingerPPG) 
N/R r = 0.76 SBP 
2015 Nabeel et al. [36] N1 = 13 22–31 BP Cuff PTT (CarotidPPG to CarotidPPG) N/R 
r = 0.5 SBP 
r = 0.66 SBP 
r = 0.63 MAP 
2015 Liu et al. [31] N1 = 12 24–35 ECG–PPG PAT PTT (TemplePPG to Index FingerPPG) N/R N/R 
2011 Chen et al. [18] N4 = 35 17–21 and 58–62 IBP PTT (EarPPG to ToePPG) 
2.16 mmHg SBP 
1.49 mmHg DBP 
N/R 
2010 Proenca et al. [32] N1 = 20 20–37 Finometer PTT (ECG, ICG, unspecified PPG) 
PTT (EarPPG to FingerPPG) 
N/R r = 0.22 SBP 
N1 = normotensive subjects, N2 = hypertensive subjects, N3 = patients undergoing coronary angiography, N4 = patients under general anesthesia, r = Pearson’s 
correlation coefficient, Finometer = finger blood pressure, IBP = invasive BP, MW = multi-wavelength, MA = motion artifact, ECG = electrocardiogram, ICG = 
impedance cardiography, PTT = pulse transit time, N/R = not reported, SBP = systolic BP, DBP = diastolic BP, MAP = mean arterial pressure, FingerPPG = PPG 
collected from a finger. 
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4. Discussion 
Of the 13 publications, only one study, Chen et al. [32], found two-channel PTT (earlobe and 
finger, N = 20) to be poorly correlated with BP. This poor correlation is suggested to be due to the fact 
that the devices used had a low accuracy and sensitivity in comparison to the small changes in PTT 
associated with the changes in BP. In their study, the PTT varied with a massive uncertainty of ±11 
ms, which was associated with a variation in the BP readings of approximately ±20 mmHg (r = 0.22).  
One of the studies, Beckmann et al. [30], only looked at the reproducibility of the measurements 
using a wrist to finger PPG (N = 5). This study had neither a gold standard for measuring the 
reference blood pressure, nor did they have any reports of accuracy of their measurements. 
However, they were able to show an excellent agreement within multiple measurements using 
different fingers (r = 0.95).  
Another study, Viejo et al. [24] used multi-site PPG with more than two locations, using raw 
video analysis of multiple locations of the face (N = 15). Using machine learning, they were able to 
create an algorithm to predict the SBP with an accuracy of r = 0.85, which is the most accurate SBP 
prediction amongst the studies included here.  
Yet another study, Chen et al. [18], used ear–toe dual PPG to measure PWV to estimate BP. The 
advantage of this study is that it was conducted on patients undergoing general anesthesia. In 
addition, this is the only study included in our analysis that examined patients of different age 
ranges (17–21 and 58–62 years). However, a limitation of their experiment is the small sample size. 
Although they had more than 30 subjects (N = 35), they separated their experimental validation into 
two separate experiments: validation of PWV (N = 9) and validation of BP measurement (N = 26). 
Furthermore, they had two different age groups; therefore, it would be ideal to have a larger sample 
size. Another limitation of the study is that there is insufficient information about the subjects. Chen 
et al. notes that data acquisition was done in the operating room before, during, and after anesthesia. 
However, how the nature of the surgeries, health of the subjects, and the use of any medication 
could affect the BP is unknown.  
4.1. Wearable PPG-Based Devices 
One of the main motivators for studying multi-site PPG is its potential for incorporation into a 
wearable device to continuously monitor BP in an ambulatory setting. This would be designed to 
allow for the early detection of HTN and provide an accurate and complete profile of BP control in 
hypertensive patients. Based on the research found, there seem to be two major barriers to creating a 
wearable device. First, the device must be compact enough to be convenient to wear on a daily basis, 
and second, PPG measurements are usually highly sensitive to body movements, where the signal 
collected contains motion artifacts that can decrease the accuracy of the BP estimation. 
4.2. Compact Design 
A second study, Liu et al. [31], proposed the use of the front and back cameras on a smartphone 
to measure PTT. The device used in the study had one camera surrounded by a ring of light-emitting 
diode (LED) lights on one side and a standalone camera on the other side. The side with the LED 
lights was pressed against the temple while the index finger of the right hand was pressed against 
the second camera, in a position similar to when one is talking on a phone. The camera for the index 
finger was illuminated using ambient light from both daylight and fluorescent lighting. One of the 
limitations of this study was that they only compared this multi-site PTT result with an 
ECG–PPG-derived PTT. They did not compare the PTT with any measurements of BP. 
One of the earliest published multi-site PPG studies, McCombie et al. [37], demonstrated how 
multiple PPG probes can be attached to a single artery on the hand in the form of an extended glove. 
Although the PTT delay is quite short, the current microcontroller technology can readily measure 
pulse timings with a microsecond accuracy and thus can be used to estimate BP changes. 
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Similarly, Nabeel et al. [16,29,34,36], explored ways to collect multi-site PPG using only one 
probe on one part of the body. They used a single device with one infrared (IR) LED and two PPG 
probes that were a fixed distance apart to measure the PTT along a single artery. This solves several 
issues. First, it eliminates the inaccuracies from estimating the distance between the two PPG probes. 
Second, when two probes are located on different body parts, there is an inaccuracy associated with 
the multiple branch points between points A and B and the multiple reflections of the wave. Lastly, 
only one device is needed. Three of the four studies used a sphygmomanometer as the gold 
standard, while one used tonometry [29]. Of the four studies, only one had a sample size of 35 
normotensive subjects [16].  
Another two studies, Liu et al. [26,35], explored the use of a single PPG device with 
multi-wavelength probes for measuring PTT. Signals with shorter wavelengths were dispersed 
superficially and represented capillaries, while longer wavelengths penetrated deeper and 
represented arterioles. The time difference between IR-PPG (“arterioles”) and blue-PPG 
(“capillaries”) was used to calculate PTT. This PTT was then compared with the ECG–PPG PTT. The 
BP was simultaneously compared with a reference BP. The benefit of this method is that it allows for 
a small device that can be worn in a single location; one of these studies suggested implementation 
into a smart watch, ring, or earbud [26]. In addition, this study had four subjects that were 
undergoing a coronary angiography. A limitation of these studies was that they used the finger 
clamp method as the gold standard. 
4.3. Imaging PPG 
More recently, it has been demonstrated that the optical pulse perfusion in the human skin can 
be measured with a camera [38]. This technique is now known as “imaging PPG” (iPPG) or “video 
plethysmography.” By processing the separate color channels in the camera image, the separate 
color channels can be combined using blind source separation methods to reconstruct the pulse 
waveform. Since a camera can measure the pulse at multiple points on the body simultaneously, 
researchers have developed a variety of methods using iPPG to estimate blood pressure.  
Hybrid techniques have also been developed. Zhang et al. [33] proposed a possible smart watch 
application using contact PPG and iPPG. The smart watch would contain a contact PPG probe for 
the wrist and a camera to analyze the face for an iPPG when the watch is raised towards head level. 
The iPPG would then use computer software to analyze the changes in light on the skin surface to 
detect the pulse wave. However, the iPPG was collected under a single fluorescent lamp only, and 
the contact PPG used in the experiment was a normal finger PPG. It is unclear how the system 
would perform under the varying spectrum of possible lighting scenarios in day-to-day living. Still, 
this study provides a proof of concept for a nonintrusive method of obtaining two PPG signals to 
calculate BP. The iPPG was first demonstrated on a smart phone by Poh et al. [39]. Fletcher et al. was 
one of the first to investigate the effect of different ambient lighting on iPPG using an Android 
phone [40]. A recent iPPG study [41], with the use of a smartphone camera, showed promising 
results toward measuring blood pressure; however, the data were collected only from normotensive 
subjects.  
4.4. Mitigating Motion Artifacts 
Only one study, Wang et al. [25], addressed the issue of motion artifacts, a key challenge to 
reliable clinical measurements with the PPG. Their study used two PPG sensors (one on the arm, one 
on the wrist) and an accelerometer at the wrist. The accelerometer was used to identify and remove 
motion artifacts from the PPG signal. The study was able to show reliable BP measurements while 
subjects were walking with a normal arm swing. While this study was performed under controlled 
laboratory settings that did not fully encompass the range of movement in day-to-day living, it did 
show that motion artifacts can often be accounted for and its effects mitigated via signal processing, 
but that this is a key area of development needed for ambulatory PPG-based BP assessments.
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5. Recommendations 
As mentioned in the introduction, a vast majority of the publications use the term “multi-site 
PPG” to describe a dual PPG system. In our literature search, there was only one study that used 
more than two PPGs in the analysis of BP. This study used PPG analysis of three facial regions in 
combination with machine learning in order to develop an algorithm for BP prediction [24]. In 
addition, PTT and PAT are routinely used interchangeably. Our recommendation is: 
(1) to apply all recommendations in Elgendi [12] but in multiple PPG configurations, 
(2) to compare the performance features extracted from signal PPG signals and multiple PPG 
signals for assessing BP, 
(3) to optimize the locations of measurement for extracting PTT that are correlated with BP, 
(4) to include more unhealthy subjects with co-morbidities, 
(5) to include subjects from different age ranges, 
(6) to explore different noisy environments, and 
(7) to investigate the integration of multiple PPG sensors (contact and non-contact) in intelligent 
clothing or wearable devices. 
A thorough literature search using PubMed revealed only 13 publications from January 2010 to 
January 2019 regarding the use of multi-site PPG for BP estimation. The research suggests that PPG 
simultaneously from a range of body sites is a promising approach for the continuous tracking of BP. 
The current research landscape is lacking given the increasing need for a technology to continuously 
and non-invasively monitor BP. The main shortcoming is that a majority of research studies do not 
have large enough sample sizes, nor do they include participants with co-morbidities. That being 
said, a surprising number of studies used a method of BP provocation, showing that their 
approaches are sensitive to changes in BP. There were also many different approaches to creating a 
device that would be convenient to wear on a daily basis. The direction of future research should be 
toward validating the proposed technologies using larger sample sizes and broader populations. 
6. Conclusions 
A systematic review of multi-site PPG-based blood pressure measurement studies from January 
2010 to January 2019 was conducted, revealing that there were many studies with promising PPG 
technologies, but were not mature enough to make a powerful and statistically significant 
contribution toward the reliable non-invasive measurement of arterial blood pressure. This review 
creates the necessary motivation for research groups around the globe to intensify their efforts 
toward the creation of a much needed disruptive technology offering non-invasive, cuff-less, 
continuous, and calibration-free measurement of blood pressure. 
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Appendix 
The titles (translated into English) of articles that are not accessible in English language: 
(Clinical effect of lower tidal volume combined with lung recruitment maneuver on ARDS for 
post-operative esophageal carcinoma surgery patients). 
(Comparison of early retinal microvascular changes and microalbuminuria as indicators for 
increased cardiovascular risk). 
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(Pilot study: Wrist digital sphygmomanometers as an alternative for non-invasive blood 
pressure measurement in pediatric population). 
(Ventilation strategies for chronic obstructive pulmonary disease). 
(Results of using the dosing Valsalva–Weber test to determine autonomic disorders in patients 
with vasovagal syncope). 
(Monitoring oxygen consumption in energy metabolism in pediatric anesthesia: clinical utility). 
(Pulmonary hypertension: a rare cause of unexplained dyspnea). 
(Minimally invasive treatment of Dupuytren’s contracture using Pi needle percutaneous 
multi-segmental fasciotomy). 
(Analysis of thyroid homeostasis disorders in patients with severe traumatic brain injury). 
(Central sleep apnea (Ondine’s curse syndrome) in medullary infarction). 
(The coronary patient six months after cardiac rehabilitation: rehabilitation evaluation research 
(RER study)). 
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